Recce Pharmaceuticals Ltd (RCE.AX) - Stock Prices, Stock Peers & Analysis

Home
RCE.AX

Company Name	Recce Pharmaceuticals Ltd
Symbol	RCE.AX
Currency	AUD
Price	0.475
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	110,139,200
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	0.41 - 0.695
Industry	Biotechnology
Sector	Healthcare
CEO	Mr. James Hamilton-Bray Graham GAICD
Website	https://www.recce.com.au

An error occurred while fetching data.

About Recce Pharmaceuticals Ltd

Recce Pharmaceuticals Ltd, a biotechnology company, engages in the research, development, and commercialization of synthetic antiinfectives in Australia, the United States, and the United Kingdom. The company's lead candidate is RECCE 327 to treat blood infections and sepsis derived from E. coli and S. aureus bacteria, including their superbug forms.